Modafinil in the treatment of excessive sleepiness

Por Schwartz, Jonathan RL
Publicado em 2009

Neurophysiology of Sleep and Wakefulness: Basic Science and Clinical Implications

Por Schwartz, Jonathan R.L, Roth, Thomas
Publicado em 2008

Armodafinil in the treatment of sleep/wake disorders

Por Schwartz, Jonathan RL, Roth, Thomas, Drake, Chris
Publicado em 2010

Time to Response with Sodium Oxybate for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

Por Bogan, Richard K., Roth, Thomas, Schwartz, Jonathan, Miloslavsky, Maja
Publicado no J Clin Sleep Med (2015)

Recognition and Management of Excessive Sleepiness in the Primary Care Setting

Por Schwartz, Jonathan R. L., Roth, Thomas, Hirshkowitz, Max, Wright, Kenneth P.
Publicado em 2009

Acupuncture Safety in Patients Receiving Anticoagulants: A Systematic Review

Por McCulloch, Michael, Nachat, Arian, Schwartz, Jonathan, Casella-Gordon, Vicki, Cook, Joseph
Publicado no Perm J (2015)

Tolerability and Efficacy of Armodafinil in Naïve Patients with Excessive Sleepiness Associated with Obstructive Sleep Apnea, Shift Work Disorder, or Narcolepsy: A 12-Month, Open-L...

Por Schwartz, Jonathan R.L., Khan, Arifulla, McCall, W. Vaughn, Weintraub, James, Tiller, Jane
Publicado em 2010

IT-02 INITIATION OF CLINICAL STUDIES WITH SL-701, A SYNTHETIC MULTI-PEPTIDE VACCINE WITH ENHANCED IMMUNOSTIMULATORY PROPERTIES TARGETING MULTIPLE GLIOMA-ASSOCIATED ANTIGENS, IN ADU...

Por Boockvar, John, Bodhinayake, Imithri, Brooks, Chris, Chen, Janice, Schwartz, Jonathan, Rowinsky, Eric, Reardon, David
Publicado em 2014

Symptom Distress in Patients with End-Stage Liver Disease toward the End of Life

Por Hansen, Lissi, Leo, Michael C., Chang, Michael F., Zaman, Atif, Naugler, Willscott, Schwartz, Jonathan
Publicado no Gastroenterol Nurs (2015)

Myocardial Bridge and Acute Plaque Rupture

Por Perl, Leor, Daniels, David, Schwartz, Jonathan, Tanaka, Shige, Yeung, Alan, Tremmel, Jennifer A., Schnittger, Ingela
Publicado no J Investig Med High Impact Case Rep (2016)

Evaluation of the Safety of Modafinil for Treatment of Excessive Sleepiness

Por Roth, Thomas, Schwartz, Jonathan R.L., Hirshkowitz, Max, Erman, Milton K., Dayno, Jeffrey M., Arora, Sanjay
Publicado em 2007

Synergistic anti-leukemic interactions between ABT-199 and panobinostat in acute myeloid leukemia ex vivo

Por Schwartz, Jonathan, Niu, Xiaojia, Walton, Eric, Hurley, Laura, Lin, Hai, Edwards, Holly, Taub, Jeffrey W, Wang, Zhihong, Ge, Yubin
Publicado no Am J Transl Res (2016)

Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection

Por Sugimoto, Kazushi, Kaplan, David E., Ikeda, Fusao, Ding, Jin, Schwartz, Jonathan, Nunes, Frederick A., Alter, Harvey J., Chang, Kyong-Mi
Publicado em 2005

A randomized non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castrat...

Por Hussain, Maha, Rathkopf, Dana, Liu, Glenn, Armstrong, Andrew, Kelly, Wm. Kevin, Ferrari, Anna, Hainsworth, John, Joshi, Adarsh, Hozak, Rebecca R., Yang, Ling, Schwartz, Jonathan D., Higano, Celestia S.
Publicado no Eur J Cancer (2015)

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer

Por Garcia-Carbonero, Rocio, Rivera, Fernando, Maurel, Joan, Ayoub, Jean-Pierre M., Moore, Malcolm J., Cervantes, Andres, Asmis, Timothy R., Schwartz, Jonathan D., Nasroulah, Federico, Ballal, Shaila, Tabernero, Josep
Publicado em 2014

Pleiotropic Stromal Effects of Vascular Endothelial Growth Factor Receptor 2 Antibody Therapy in Renal Cell Carcinoma Models

Por Duignan, Inga J, Corcoran, Erik, Pennello, Anthony, Plym, Mary Jane, Amatulli, Michael, Claros, Nidia, Iacolina, Michelle, Youssoufian, Hagop, Witte, Larry, Samakoglu, Selda, Schwartz, Jonathan, Surguladze, David, Tonra, James R
Publicado em 2011

Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastat...

Por Reidy, Diane Lauren, Vakiani, Efsevia, Fakih, Marwan G., Saif, Muhammad Wasif, Hecht, Joel Randolph, Goodman-Davis, Noah, Hollywood, Ellen, Shia, Jinru, Schwartz, Jonathan, Chandrawansa, Kumari, Dontabhaktuni, Aruna, Youssoufian, Hagop, Solit, David B., Saltz, Leonard B.
Publicado em 2010

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Por Siegel, Abby B., Cohen, Emil I., Ocean, Allyson, Lehrer, Deborah, Goldenberg, Alec, Knox, Jennifer J., Chen, Helen, Clark-Garvey, Sean, Weinberg, Alan, Mandeli, John, Christos, Paul, Mazumdar, Madhu, Popa, Elizabeta, Brown, Robert S., Rafii, Shahin, Schwartz, Jonathan D.
Publicado em 2008

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Por Zhu, Andrew X., Finn, Richard S., Mulcahy, Mary, Gurtler, Jayne, Sun, Weijing, Schwartz, Jonathan D., Dalal, Rita P., Joshi, Adarsh, Hozak, Rebecca R., Xu, Yihuan, Ancukiewicz, Marek, Jain, Rakesh K., Nugent, Francis W., Duda, Dan G., Stuart, Keith
Publicado no Clin Cancer Res (2013)

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma(,)

Por Penson, Richard T., Moore, Kathleen M., Fleming, Gini F., Braly, Patricia, Schimp, Veronica, Nguyen, Hoa, Matulonis, Ursula A., Banerjee, Susana, Haluska, Paul, Gore, Martin, Bodurka, Diane C., Hozak, Rebecca R., Joshi, Adarsh, Xu, Yihuan, Schwartz, Jonathan D., McGuire, William P.
Publicado no Gynecol Oncol (2014)